Cellares announced strategic partnerships with technology providers including Tecan, Advanced Instruments, and Cytek Biosciences to enhance its Cell Q automated quality control platform for cell therapies. Cell Q is designed to automate labor-intensive release assays for cell manufacturing, enabling throughput up to 6,000 batches annually. This modular and configurable system integrates hardware, software, and reagents to streamline critical QC testing, supporting the scalability needs of commercial cell therapy production. Results and case studies featuring automated vector copy number quantification will be presented at the upcoming CAR-TCR Summit.